Federal Register / Vol. 89, No. 195 / Tuesday, October 8, 2024 / Notices 81579 

Electronic copies of this Federal 

Register notice are available at http://

www.regulations.gov. This notice, as 

well as news releases and other relevant 

information, are also available on the 

Advisory Board’s web page at http://

www.dol.gov/owcp/energy/regs/ 

compliance/AdvisoryBoard.htm. 

For further information regarding this 

meeting, you may contact Ryan Jansen, 

Designated Federal Officer, at 

jansen.ryan@dol.gov, or Carrie Rhoads, 

Alternate Designated Federal Officer, at 

rhoads.carrie@dol.gov, U.S. Department 

of Labor, 200 Constitution Avenue NW, 

Suite S–3524, Washington, DC 20210, 

telephone (202) 343–5580. 

This is not a toll-free number. 

Signed at Washington, DC, this 3rd day of 

October, 2024. 

Christopher Godfrey, 

Director, Office of Workers’ Compensation 

Programs. 

[FR Doc. 2024–23266 Filed 10–7–24; 8:45 am] 

BILLING CODE 4510–CR–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Meeting Notice 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Notice of meeting. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) will convene a 

meeting of the Advisory Committee on 

the Medical Uses of Isotopes (ACMUI) 

on November 4–5, 2024. A sample of 

agenda items to be discussed during the 

public session includes: an overview of 

the Advance Act; an update on the 

Medical Radiation Safety Team’s 

activities; ACMUI bylaws update; status 

of patient release guidance revision; 

NRC review of recent yttrium-90 

microsphere medical events; and NRC 

evaluation of current patient waste 

regulations and guidance. The agenda is 

subject to change. The current agenda 

and any updates will be available on the 

ACMUI’s Meetings and Related 

Documents web page at https://

www.nrc.gov/reading-rm/doccollections/acmui/meetings/2024.html 

or by emailing Ms. L. Armstead and T. 

Roszkowski at the contact information 

below. 

Purpose: Discuss issues related to 10 

CFR part 35 Medical Use of Byproduct 

Material. 

Date and Time for Open Sessions: 

November 4, 2024, from 10:00 a.m. to 

4:35 p.m. EST. 

Date and Time for Closed Session: 

November 5, 2024, from 9:30 a.m. to 

11:30 a.m. EST. This session will be 

closed to conduct the ACMUI’s required 

annual training. 

Address for Public Meeting: This is a 

virtual meeting 

Date Webinar information (Microsoft Teams) 

November 4–5, 2024 ................................................................ Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_

M2Q3MzczZWUtNGUxZS00ZWNlL

ThmNmUtNjM4Y2ZhYTYxYTA0%40thread.v2/0?context=%7b%22Tid%22%3

a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22O

id%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d. 

Meeting ID: 294 578 901 723. 

Passcode: UaHF5t. 

Call in number (audio only): +1 301–576–2978, Silver Spring, MD. 

Phone Conference ID: 277 173 020#. 

Public Participation: Any member of 

the public who wishes to participate in 

the teleconference should contact Ms. 

Armstead and Ms. Roszkowski using the 

contact information below. 

Contact Information: Ms. L. 

Armstead, email: lxa5@nrc.gov and Ms. 

T. Roszkowski, email: vnr@nrc.gov. 

Conduct of the Meeting 

The ACMUI Chair, Dr. Hossein Jadvar, 

will preside over the meeting. Dr. Jadvar 

will conduct the meeting in a manner 

that will facilitate the orderly conduct of 

business. The following procedures 

apply to public participation in the 

meeting: 

1. Persons who wish to provide a 

written statement should submit an 

electronic copy to Ms. L. Armstead and 

Ms. T. Roszkowski using the contact 

information listed above. All submittals 

must be received by the close of 

business on October 29, 2024, and must 

only pertain to the topics on the agenda. 

2. Questions and comments from 

members of the public will be permitted 

during the meeting, at the discretion of 

the ACMUI Chair. 

3. The draft transcript and meeting 

summary will be available on ACMUI’s 

website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/

2024.html on or about December 17, 

2024. 

4. Persons who require special 

services, such as those for the hearing 

impaired, should notify Ms. L. 

Armstead and Ms. T. Roszkowski of 

their planned participation. 

This meeting will be held in 

accordance with the Atomic Energy Act 

of 1954, as amended (primarily Section 

161a); the Federal Advisory Committee 

Act (5 U.S.C. App); and the 

Commission’s regulations in title 10 of 

the Code of Federal Regulations, part 7. 

Dated at Rockville, Maryland this this 2nd 

day of October, 2024. 

For the U.S. Nuclear Regulatory 

Commission. 

Russell E. Chazell, 

Federal Advisory Committee Management 

Officer. 

[FR Doc. 2024–23168 Filed 10–7–24; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 70–3103; NRC–2024–0176] 

Louisiana Energy Services, LLC, dba 

Urenco USA; National Enrichment 

Facility; License Amendment 

Application 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Opportunity to request a hearing 

and to petition for leave to intervene; 

order imposing procedures. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) staff accepted and 

docketed an application for the 

amendment of Special Nuclear 

Materials License No. SNM–2010, 

submitted by Louisiana Energy Services, 

LLC, dba Urenco USA dated November 

30, 2023. The amended license would 

authorize the applicant to modify the 

National Enrichment Facility, located in 

Eunice, New Mexico, to increase 

enrichment from 5.5 weight percent 

Uranium-235 (U–235) to less than 10 

weight percent U–235. Because this 

amendment request contains Sensitive 


ddrumheller on DSK120RN23PROD with NOTICES1